Safety and Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution

Inclusion Criteria Subjects who have one or both eyes that meet criteria 1-4 and also meet at least 1 or more of criteria 5-11 will be considered candidates for this study: 1. 8 years of age or older 2. Signed written informed consent 3. Willingness and ability to comply with schedule for follow-up visits 4. Contact Lens Wearers Only: 1. Removal of contact lenses for the required period of time prior to the screening refraction: Contact Lens Type Minimum Discontinuation Time Soft 3 days Soft Extended Wear 3 days Soft Toric 3 days Rigid gas permeable 2 Weeks 2. Subjects who cannot function without wearing their contact lenses, may forgo discontinuation of contact lenses. 5. Presence of central or inferior steepening. 6. Axial topography consistent with keratoconus, post-surgical ectasia, or pellucid marginal degeneration 7. Presence of one or more findings associated with keratoconus or pellucid marginal degeneration, such as: 1. Fleischer ring 2. Vogt's striae 3. Decentered corneal apex 4. Munson's sign 5. Rizzutti's sign 6. Apical Corneal scarring consistent with Bowman's breaks 7. Scissoring of the retinoscopic reflex 8. Crab-claw appearance on topography 8. Steepest keratometry (Kmax) value ≥ 47.20 D 9. I-S keratometry difference \> 1.5 D on the Pentacam/Orbscan map or topography map 10. Posterior corneal elevation \>16 microns 11. Thinnest corneal point \>300 microns